Cite
MLA Citation
Nilo Riva et al.. “Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.” Lancet neurology, vol. 18, no. 2, 2019, pp. 155–164. http://access.bl.uk/ark:/81055/vdc_100076797390.0x000007